Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia

BACKGROUND: Excessive inflammation contributes to the morbidity and mortality of severe coronavirus disease 2019 (COVID-19) pneumonia. Recombinant human plasma gelsolin (rhu-pGSN) improves disease outcomes in diverse experimental models of infectious and noninfectious inflammation. METHODS: In a bli...

Descripción completa

Detalles Bibliográficos
Autores principales: DiNubile, Mark J, Parra, Sandra, Salomó, Antoni Castro, Levinson, Susan L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345409/
https://www.ncbi.nlm.nih.gov/pubmed/35928505
http://dx.doi.org/10.1093/ofid/ofac357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345409/
https://www.ncbi.nlm.nih.gov/pubmed/35928505
http://dx.doi.org/10.1093/ofid/ofac357

Ejemplares similares